NuvoResearch.com NuvoResearch.com
Mailing ListMailing ListContactsContactsStock QuoteStock QuoteSite MapSite Map
Transdermal Delivery
Immune Regulation
Home
Company Company
History & Milestones
Executive Team
Subsidiaries
Distribution Partners
Pipeline Pipeline
Transdermal Drug Delivery
Immune Regulation
Technology Technology
MMPE
HTE
Investors Investors
News Releases
Financial Reports
Webcasts and Presentations
Corporate Governance
Shareholder Information
Info Request
Publications Publications
Transdermal Delivery
Immune Regulation
Technology
Careers Careers

Investors


Stock Symbol:
TSX - NRI
Shares Outstanding:
392 million
Latest News:
2010
Year-End Financial Reports:

2009

Annual Report:
2008
Investor Presentation:
February 2010 

This section will provide you with financial and shareholder updates including annual & quarterly reports, stock quotes and shareholder information.

To view a complete listing of Nuvo's Canadian Regulatory filings, visit The System for Electronic Document Analysis and Retrieval (SEDAR) website.

Investor relations inquiries or requests for a Nuvo investor package - please contact:

Adam Peeler
Equicom Group Inc.
416-815-0700 x225
apeeler@equicomgroup.com